---
schema_version: "secwatch.filing_event.v1"
accession: "0001479681-25-000085"
form_type: "8-K"
ticker: "NUTX"
cik: "0001479681"
company_name: "Nutex Health Inc."
filed_at: "2025-10-20T23:59:59+00:00"
generated_at: "2026-05-17T03:13:03.402577+00:00"
event_type: "earnings"
sentiment: "neutral"
materiality_score: 0.7
calibrated_materiality_score: 0.7
confidence: "medium"
source: SEC EDGAR
---

# Nutex Health Q3 prelim: cash collections up 259% YoY, patient volume +11.1%; Nasdaq extension granted

## Summary
- Preliminary Q3 2025 patient volume of 46,293 visits, up 11.1% vs Q3 2024.
- Cash collections for Q3 2025 surged 258.8% to $235M, driven by revenue cycle improvements.
- YTD 2025 cash collections $546M, up 176.9% vs YTD 2024; patient volume +14% to 140,135.
- Nasdaq extended deadline to Dec 12, 2025, for filing delinquent Q2 2025 10-Q.
- Company warns preliminary metrics are unaudited and subject to change upon final review.

## SEC filing metadata
- accession: 0001479681-25-000085
- form_type: 8-K
- ticker: NUTX
- cik: 0001479681
- company_name: Nutex Health Inc.
- filed_at: 2025-10-20T23:59:59+00:00
- event_type: earnings
- sentiment: neutral
- materiality_score: 0.7
- calibrated_materiality_score: 0.7
- confidence: medium
- sec_items: 2.02, 3.01, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1479681/000147968125000085/0001479681-25-000085-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1479681/000147968125000085/nutx-20251020.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001479681-25-000085
- JSON: https://secwatch.observer/filing/0001479681-25-000085.json
- Plain text: https://secwatch.observer/filing/0001479681-25-000085.txt

## Source-grounded claims
- claim_id: 1fe827f58c0a3d4e208fb01d1f8f3d06f8389e43
  claim: Nutex Health Inc. received a nasdaq deficiency notice notice regarding late filing (rules 5250(c)(1)).
  evidence_excerpt: August 20, 2025, the Company received a notice (the “Notice”) from the Listing Qualifications Department of The Nasdaq Stock Market LLC (“Nasdaq”) notifying the Company that due to the Company’s failure to timely file its Quarterly Report on Form 10-Q for the period ended June 30, 2025 (the “June 30, 2025 Form 10-Q”) with the Securities and Exchange Commission (the “SEC”), the Company is not in compliance with Nasdaq’s continued listing requirements under Nasdaq Listing Rule 5250(c)(1) (the “Rule”), which requires the timely filing of all required periodic reports with the SEC. On October 15
  evidence_url: https://www.sec.gov/Archives/edgar/data/1479681/000147968125000085/0001479681-25-000085-index.htm
- claim_id: 4c889287914975bb6a10f2793bfa2369cc2ce657
  claim: Nutex Health Inc. received a nasdaq extension granted notice regarding late filing (rules 5250(c)(1)).
  evidence_excerpt: October 16, 2025. In the event the Company is not able to file the June 30, 2025 Form 10-Q with the SEC on or before December 12, 2025, the staff of Nasdaq will issue a delisting notice, which the Company may appeal to a Nasdaq Hearings Panel.
  evidence_url: https://www.sec.gov/Archives/edgar/data/1479681/000147968125000085/0001479681-25-000085-index.htm

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.